NIH-funded research Fellowship grant

Investigating how a specific enzyme affects brain function and behavior in Alzheimer's disease

Official title: The role of beta-secretase 1 (BACE1) in modulating excitatory synaptic and circuit function and behavior

Funded at University of Connecticut Sch of Med/dnt · NIH-11004678 · Data updated 2026-11-12

This study is looking at how a protein called BACE1 affects memory and brain function in mice with Alzheimer's, hoping to find new ways to help people with the disease.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Connecticut Sch of Med/dnt
NIH-funded
Lab location1 site (Farmington, United States)
Project startFebruary 22, 2023
Project endFebruary 21, 2027
Funding year2025
Award (this year)$53,974
NIH project number5F30AG081134-03
Project IDNIH-11004678 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 21 and older who are at risk for or diagnosed with Alzheimer's disease.

Less likely to help

Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.

What this research studies

This research focuses on understanding the role of beta-secretase 1 (BACE1) in the brain, particularly how it influences neuronal and synaptic functions related to memory. By studying mouse models of Alzheimer's disease, the researchers aim to uncover the mechanisms by which BACE1 affects brain circuits and behavior. The approach involves detailed physiological assessments of neurons in the hippocampus, a critical area for memory, to determine how changes in BACE1 levels impact cognitive functions. This research seeks to bridge the gap between laboratory findings and potential clinical applications for Alzheimer's treatment.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for Alzheimer's disease that improve cognitive function and slow disease progression.

How similar studies have gone: While there have been challenges with BACE1 inhibitors in clinical trials, this research aims to provide new insights that could lead to successful interventions, making it a novel approach.

Where this research is happening

  • University of Connecticut Sch of Med/dnt
    Farmington, United States
    Active

Researchers

  • Principal investigator: Yao, Annie Y — University of Connecticut Sch of Med/dnt
  • Study coordinator: Yao, Annie Y

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.